Dogwood Therapeutics, Inc.
DWTX
$4.99
-$0.07-1.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -32.10% | -61.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.44% | -41.27% | |||
| Operating Income | 11.44% | 41.27% | |||
| Income Before Tax | 64.53% | -38.90% | |||
| Income Tax Expenses | -99.95% | 38,200.00% | |||
| Earnings from Continuing Operations | 65.15% | -41.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 65.15% | -41.37% | |||
| EBIT | 11.44% | 41.27% | |||
| EBITDA | 11.49% | 41.47% | |||
| EPS Basic | 76.42% | -34.36% | |||
| Normalized Basic EPS | 37.57% | 45.89% | |||
| EPS Diluted | 76.42% | -34.36% | |||
| Normalized Diluted EPS | 37.57% | 45.89% | |||
| Average Basic Shares Outstanding | 32.58% | 10.00% | |||
| Average Diluted Shares Outstanding | 32.58% | 10.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||